Becker's Healthcare April 3, 2024
The FDA has approved an artificial intelligence algorithm for Eko Health’s digital stethoscope that can detect low ejection fraction, a key indicator of heart failure.
Eko Health developed the algorithm with Rochester, Minn.-based Mayo Clinic. The AI stethoscope will allow clinicians to detect low EF — when the heart does not efficiently pump blood — in about 15 seconds during routine exams.
The approval represents a milestone in the early detection of heart disease, the company said. Traditional heart failure detection methods, such as echocardiography, are often unavailable in primary care settings. This means many early-stage cases go undiagnosed until symptoms worsen...
Today's Sponsors
Today's Sponsor